Search

Your search keyword '"Catalano, Gianfranco"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Catalano, Gianfranco" Remove constraint Author: "Catalano, Gianfranco"
45 results on '"Catalano, Gianfranco"'

Search Results

1. MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs’ patients

2. PB1787: PLZF-RARΑ ENHANCES METABOLIC PLASTICITY AND ROS SCAVENGING IN AML CELLS

4. Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment

6. NPM1 mutated, BCR-ABL1 positive myeloid neoplasms: review of the literature

10. NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE

11. PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia Cells

13. Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy

14. PML/RARAinhibits expression ofHSP90 and its targetAKT

15. Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors

16. PYRROLO[1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs) induce apoptosis in K562 cells

17. Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia: Presented in part at the 41st Annual Meeting of the American Society of Hematology, December 3-7, 1999, New Orleans, LA.

18. Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation

19. High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro

21. PML/RARA inhibits expression of HSP90 and its target AKT.

22. Identification of a potential topoisomerase II “hotspot” DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms

23. PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity

24. A case of SRSF2 mutation in chronic lymphocytic leukemia

25. Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy

29. Clinical Significance of 13q14 Number of Deleted Cells in Chronic Lymphocytic Leukemia

30. Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia

32. Nucleophosmin Gene Mutations Exhibit High Spontaneous Apoptosis and Favorable Prognosis in Acute Myeloid Leukemia.

33. High CD69 Protein Expression Predicts a Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

34. PYRROLO[1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs) induce apoptosis in K562 cells

35. Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A New Class of Agents with High Apoptotic Activity in Chronic Myelogenous Leukemia K562 Cells and in Cells from Patients at Onset and Who Were Imatinib-Resistant.

38. Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation

40. Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2Splicing Factor Gene Mutations in Myelodysplastic Syndromes

41. PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity

42. Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.

43. PYRROLO[1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs)induce apoptosis in K562 cells.

44. PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia Cells.

45. NPM1 Mutated, BCR-ABL1 Positive Myeloid Neoplasms: Review of the Literature.

Catalog

Books, media, physical & digital resources